当前位置：首页>产品中心>单抗/多抗
单抗/多抗
产品名称 点击数
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody |抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体) 674
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody |抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体) 667
Anti-Ixekizumab Non-Neutralizing Recombinant Antibody |抗依奇珠单抗非中和重组抗体(靶标：依奇珠单抗非中和抗体) 938
Anti-Ixekizumab Neutralizing Recombinant Antibody |抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体) 879
Anti-Ixekizumab Neutralizing Recombinant Antibody |抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体) 849
Anti-Ixekizumab Neutralizing Recombinant Antibody |抗依奇珠单抗中和重组抗体(靶标：依奇珠单抗中和抗体) 787
Anti-Daratumumab Non-Neutralizing Recombinant Antibody|抗达雷妥尤单抗非中和重组抗体(靶标：达雷妥尤单抗非中和抗体) 955
Anti-Daratumumab Neutralizing Recombinant Antibody |抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体) 853
Anti-Daratumumab Neutralizing Recombinant Antibody |抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体) 887
Anti-Daratumumab Neutralizing Recombinant Antibody |抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体) 970
Anti-Daratumumab Neutralizing Recombinant Antibody |抗达雷妥尤单抗中和重组抗体(靶标：达雷妥尤单抗中和抗体) 913
Anti-Avelumab Non-Neutralizing Recombinant Antibody |抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体) 606
Anti-Avelumab Non-Neutralizing Recombinant Antibody |抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体) 802
Anti-Avelumab Non-Neutralizing Recombinant Antibody |抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体) 1025
Anti-Avelumab Non-Neutralizing Recombinant Antibody |抗阿维鲁单抗非中和重组抗体(靶标：阿维鲁单抗非中和抗体) 735
Anti-Avelumab Neutralizing Recombinant Antibody |抗阿维鲁单抗中和重组抗体(靶标：阿维鲁单抗中和抗体) 1029
Anti-Avelumab Neutralizing Recombinant Antibody |抗阿维鲁单抗中和重组抗体(靶标：阿维鲁单抗中和抗体) 786
Anti-Camrelizumab Neutralizing Recombinant Antibody |抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体) 894
Anti-Camrelizumab Neutralizing Recombinant Antibody |抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体) 926
Anti-Camrelizumab Neutralizing Recombinant Antibody |抗卡瑞利珠单抗中和重组抗体(靶标：卡瑞利珠单抗中和抗体) 884
总计 33037 个记录，共 1652 页，当前第 1648 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线：
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30